Copyright Reports & Markets. All rights reserved.

Global Neratinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Neratinib Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 40mg/180 Tablets
      • 1.2.2 40mg/150 Tablets
      • 1.2.3 40mg/90 Tablets
    • 1.3 Market Analysis by Applications
      • 1.3.1 Early Breast Cancer
      • 1.3.2 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Puma Biotechnology
      • 2.1.1 Business Overview
      • 2.1.2 Neratinib Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Puma Biotechnology Neratinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Beacon Pharmaceuticals Limited
      • 2.2.1 Business Overview
      • 2.2.2 Neratinib Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Beacon Pharmaceuticals Limited Neratinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Neratinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Neratinib Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Neratinib Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Neratinib Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Neratinib Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Neratinib Market Analysis by Regions

    • 4.1 Global Neratinib Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Neratinib Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Neratinib Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Neratinib Sales and Growth Rate (2014-2019)
    • 4.3 Europe Neratinib Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Neratinib Sales and Growth Rate (2014-2019)
    • 4.5 South America Neratinib Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Neratinib Sales and Growth Rate (2014-2019)

    5 North America Neratinib by Country

    • 5.1 North America Neratinib Sales, Revenue and Market Share by Country
      • 5.1.1 North America Neratinib Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Neratinib Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Neratinib Sales and Growth Rate (2014-2019)
    • 5.3 Canada Neratinib Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Neratinib Sales and Growth Rate (2014-2019)

    6 Europe Neratinib by Country

    • 6.1 Europe Neratinib Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Neratinib Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Neratinib Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Neratinib Sales and Growth Rate (2014-2019)
    • 6.3 UK Neratinib Sales and Growth Rate (2014-2019)
    • 6.4 France Neratinib Sales and Growth Rate (2014-2019)
    • 6.5 Russia Neratinib Sales and Growth Rate (2014-2019)
    • 6.6 Italy Neratinib Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Neratinib by Country

    • 7.1 Asia-Pacific Neratinib Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Neratinib Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Neratinib Revenue and Market Share by Country (2014-2019)
    • 7.2 China Neratinib Sales and Growth Rate (2014-2019)
    • 7.3 Japan Neratinib Sales and Growth Rate (2014-2019)
    • 7.4 Korea Neratinib Sales and Growth Rate (2014-2019)
    • 7.5 India Neratinib Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Neratinib Sales and Growth Rate (2014-2019)

    8 South America Neratinib by Country

    • 8.1 South America Neratinib Sales, Revenue and Market Share by Country
      • 8.1.1 South America Neratinib Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Neratinib Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Neratinib Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Neratinib Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Neratinib Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Neratinib by Countries

    • 9.1 Middle East and Africa Neratinib Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Neratinib Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Neratinib Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Neratinib Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Neratinib Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Neratinib Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Neratinib Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Neratinib Sales and Growth Rate (2014-2019)

    10 Global Neratinib Market Segment by Type

    • 10.1 Global Neratinib Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Neratinib Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Neratinib Revenue and Market Share by Type (2014-2019)
    • 10.2 40mg/180 Tablets Sales Growth and Price
      • 10.2.1 Global 40mg/180 Tablets Sales Growth (2014-2019)
      • 10.2.2 Global 40mg/180 Tablets Price (2014-2019)
    • 10.3 40mg/150 Tablets Sales Growth and Price
      • 10.3.1 Global 40mg/150 Tablets Sales Growth (2014-2019)
      • 10.3.2 Global 40mg/150 Tablets Price (2014-2019)
    • 10.4 40mg/90 Tablets Sales Growth and Price
      • 10.4.1 Global 40mg/90 Tablets Sales Growth (2014-2019)
      • 10.4.2 Global 40mg/90 Tablets Price (2014-2019)

    11 Global Neratinib Market Segment by Application

    • 11.1 Global Neratinib Sales Market Share by Application (2014-2019)
    • 11.2 Early Breast Cancer Sales Growth (2014-2019)
    • 11.3 Other Sales Growth (2014-2019)

    12 Neratinib Market Forecast (2019-2024)

    • 12.1 Global Neratinib Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Neratinib Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Neratinib Market Forecast (2019-2024)
      • 12.2.2 Europe Neratinib Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Neratinib Market Forecast (2019-2024)
      • 12.2.4 South America Neratinib Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Neratinib Market Forecast (2019-2024)
    • 12.3 Neratinib Market Forecast by Type (2019-2024)
      • 12.3.1 Global Neratinib Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Neratinib Market Share Forecast by Type (2019-2024)
    • 12.4 Neratinib Market Forecast by Application (2019-2024)
      • 12.4.1 Global Neratinib Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Neratinib Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Scope of the Report:
      The worldwide market for Neratinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Neratinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Puma Biotechnology
      Beacon Pharmaceuticals Limited

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      40mg/180 Tablets
      40mg/150 Tablets
      40mg/90 Tablets

      Market Segment by Applications, can be divided into
      Early Breast Cancer
      Other

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Neratinib product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Neratinib, with price, sales, revenue and global market share of Neratinib in 2017 and 2018.
      Chapter 3, the Neratinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Neratinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Neratinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Neratinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now